-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
January 01, 2010 - Indirect/media (location at time of exposure—degree of
safety)
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
September 06, 2023 - access to care, affordable care, care coordination, effective treatment, healthy living,
patient safety … disparities measurement, race equity, gender equity, geographic equity, quality of care
measurement, patient safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
September 06, 2023 - to access to care, affordable care,
care coordination, effective treatment, healthy living, patient safety … Furthermore, AHRQ has identified new priority areas1 of health and access to care, i.e.,
patient safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
April 01, 2023 - Interventions
• Studies to determine the optimal structure and
safety for routine and alternative … depression, fear of partner, coercive control,
self-efficacy, post-traumatic stress disorder, and
safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
October 01, 2016 - attention on the strength and limits of evidence from research studies about the effectiveness and
safety … Program
Asarnow, 201536 Educational/skill building (SAFETY Cognitive-Behavioral Family
Treatment … Jail
records
Cooper, 200660 Logistic regression County Living in a county that
offered a minimum safety … The
Treatment for Adolescents With Depression
Study (TADS): long-term effectiveness and
safety outcomes … The Treatment for Adolescents With Depression
Study (TADS): long-term effectiveness and safety outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … Table C summarizes the key findings for each KQ,
including the modifiers of effectiveness and safety … In addition, the safety concerns or harms of these treatment
strategies are underreported for women
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - Meta-analyses of safety data: a comparison of exact versus asymptotic methods. … Meta-analyses of safety data: a comparison of exact versus asymptotic methods.
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - The key informants felt that this safety analysis would be a reasonable thing to do, so we performed … KQ 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted by rhGH … KQ 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of treatment … Key question 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted … Key question 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - Management of Infertility Evidence Summary
Purpose of Review
Evaluate the comparative effectiveness and safety … Different treatments also carry different safety
risks. … What are the comparative safety and
effectiveness of available treatment strategies for
women with … What are the comparative safety and
effectiveness of available treatment strategies
for women with … What are the comparative safety and
effectiveness of available treatment strategies for
women with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - However, SBRT efficacy and safety data are derived from
lower quality studies with variable exclusion … Practitioners should closely adhere to quality and safety
considerations for SBRT delivery as described … Once again, practitioners should use existing ASTROwhite
paper safety recommendations.14 In general, … ASTRO guidelines present scientific, health, and safety
information and may reflect scientific or medical … Quality and safety
considerations in stereotactic radiosurgery and stereotactic body radiation
therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - All the
same issues noted for RA of short- and long-term risks
and safety, as well as performance in … and
observational studies is insufficient to draw conclusions
about the comparative tolerability and safety … biologics that met our eligibility criteria;1-8 five of these
were observational studies assessing the safety … Safety and efficacy of
adalimumab in treatment of patients with psoriatic
arthritis who had failed disease
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
December 01, 2013 - prescription on the Internet by a company in Boise, ID
(ABC Nutriceuticals, Inc.), although information on safety … of other medications for this
indication, the ease of oxytocin administration, and its favorable safety … hypothalamus, and nucleus
accumbens.5-8 Based on these findings, clinical trials are examining oxytocin’s safety … Internet from at least one company, ABC Nutriceuticals, Inc., Boise, ID,
although information on safety
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
January 01, 2009 - In
Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the
new … limited
numbers of human subjects to gather preliminary evidence regarding effectiveness and additional
safety … Phase III refers to controlled clinical studies intended to provide a reasonable
assurance of safety … studies
performed once a technology has gained marketing approval; these studies address long-term
safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
January 01, 2009 - In
Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the
new … limited
numbers of human subjects to gather preliminary evidence regarding effectiveness and additional
safety … Phase III refers to controlled clinical studies intended to provide a reasonable
assurance of safety … studies
performed once a technology has gained marketing approval; these studies address long-term
safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-infections_disposition-comments.pdf
August 10, 2015 - In all
of patient safety we need more rigorous conceptual
frameworks that translate into models with … professionalism of
environmental services personnel, and
emphasized their central role in patient
safety … Part of this is discussed in
the section on patient safety culture (page 16 and
following), but a key … KI Reviewer 3 Findings P23, L25 - The contents under the subheading “Patient
Safety Culture” provide … A safety concern
with improper use is airway and mucous
membrane irritation.”
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - complexity of this decisionmaking process is a lack of
clarity regarding the comparative efficacy and safety … clinicians, and payers to have reliable estimates
of KC treatments’ comparative effectiveness and safety … this systematic review is to comprehensively collect information on the comparative
effectiveness and safety … Comments About the Eligibility Criteria
Because the key questions are about comparative effectiveness and safety
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
April 15, 2019 - , patient registries can provide unique insights into
real-world clinical practice, effectiveness, safety … Food and Drug Administration (FDA) uses registries in assessing the safety
and effectiveness of drugs … found that different
definitions of bleeding “can lead to markedly different conclusions about the safety … Areas for measurement include (a) affordable care, (b) patient safety, (c) person-
and family-centered … Common Formats for
Patient Safety Data. 2014.
http://www.qualityforum.org/ProjectDescription.aspx
?
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - These safety concerns may present barriers to
approval or barriers to diffusion if approved. … determinations stated MSC therapy is investigational because of insufficient evidence or long-term
safety … Both groups had similar safety
profiles.
29
In a study of patients with knee OA (Outerbridge grades … (which has yet to be determined), but some of the
experts expressed strong concerns regarding its safety … These safety concerns may
present significant barriers to approval and diffusion if approved.
-
effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
January 01, 2012 - injuries caused by HBOT, so the treatment
is controversial not only on the basis of efficacy, but on safety … Comments: Experts commenting on this intervention expressed concern about
the underlying theory and safety … impending severe emotional distress could be critical to more effective management and increased
safety … The expert indicated the intervention may pose safety issues in patients
with otitis media and asthma … Safety concerns, the closed environment of the HBOT chamber
(which could cause claustrophobia), and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - would strongly benefit from the statement on page ES-
11: No studies were identified examining the safety … Page ES-14 Research Gaps: “These agents are unregulated and
safety data may be limited or absent.” … The authors’ actual conclusion
was that the safety data ARE limited or absent, not that they may be … Their focus on
the lack of evidence on compounded HT (safety and efficacy) being
used by millions of … A review of
evidence for all safety data for the nonhormonal
agents was beyond the scope of the review